Fox Chase Cancer Center and Russian Cancer Center Form Relationship
PHILADELPHIA (November 3, 2000)—Fox Chase Cancer Center and the Irkutsk Regional Oncology Center in Irkutsk, Siberia Russia solidify their clinical and research relationship with the signing of a Memorandum of Understanding when leading Russian oncologists visit Philadelphia on Monday, November 6, 2000. The signing takes place at 1:45 p.m. in the Reimann Building room 243.
Victoria Dvornichencko, M.D., chief of the Irkutsk Regional Oncology Center, will spend one day at Fox Chase Cancer Center in preparation for the signing. She will be joined by Galina Kalenaeva, a Russian advisor from the United Nations Development Program. The group will finalize the goals for the relationship which include surgical training, collaboration on patient diagnosis, courses in radiation treatment, physician educational exchanges, and treatment at Fox Chase Cancer Center for Irkutsk private patients interested in traveling to Philadelphia for therapeutic interventions.
"Our objective is to improve the level of care in the Irkutsk region by establishing a multi-dimensional program for cancer treatment and professional medical education," explains Paul F. Engstrom, senior vice president of the Population Science division of Fox Chase Cancer Center. Earlier this year, Engstrom was a signer of the Charter Against Cancer, a document signed in Paris, France by world leaders in oncology. The Charter pledges international support for cancer treatment to all patients.
"The mission of Fox Chase Cancer Center is to reduce the burden of human cancer. That statement doesn't exclude people living outside America's borders," adds Engstrom. A medical oncologist, Engstrom has completed two trips to Russia and most recently met with the chief oncologist from the Health Ministry of Russia and visited two leading cancer centers in Moscow.
"These physicians are gifted, but the extent of the care they can offer is limited because not enough money is provided for infrastructure development," says Engstrom.
Several activities are planned for the Fox Chase visit on Nov. 6th leading up to the signing of the Memorandum of Understanding. The delegation arrives at 10 a.m. to meet with the Robert C. Young, president of Fox Chase Cancer Center. Following a tour of the center, the Russian visitors will meet with physicians who have already committed to participation in the program. Then at a 1:00 p.m. luncheon, the leaders of Fox Chase Cancer Center and Irkutsk Regional Oncology Center sign the Memorandum of Understanding.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.